1. Bradová, Martina, Mosaieby, Elaheh, Michal, Michael, Michal, Michal, Švajdler, Marián. 2023. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature. In Histopathology, 84, 776-793. doi:10.1111/his.15121. https://pubmed.ncbi.nlm.nih.gov/38114270/
2. Kotarba, Grzegorz, Krzywinska, Ewa, Grabowska, Anna I, Taracha, Agnieszka, Wilanowski, Tomasz. 2018. TFCP2/TFCP2L1/UBP1 transcription factors in cancer. In Cancer letters, 420, 72-79. doi:10.1016/j.canlet.2018.01.078. https://pubmed.ncbi.nlm.nih.gov/29410248/
3. Wang, Linglu, Liu, Xiaoyan, Han, Yuhang, Chen, Hongbo, Cheng, Fang. 2024. TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanoma. In Cancer letters, 590, 216861. doi:10.1016/j.canlet.2024.216861. https://pubmed.ncbi.nlm.nih.gov/38583649/
4. Watson, Sarah, Perrin, Virginie, Guillemot, Delphine, Delattre, Olivier, Tirode, Franck. 2018. Transcriptomic definition of molecular subgroups of small round cell sarcomas. In The Journal of pathology, 245, 29-40. doi:10.1002/path.5053. https://pubmed.ncbi.nlm.nih.gov/29431183/
5. Basu, Amrita, Champagne, Rachel N, Patel, Neil G, Nicholson, Elijah D, Weiss, Ryan J. 2023. TFCP2 is a transcriptional regulator of heparan sulfate assembly and melanoma cell growth. In The Journal of biological chemistry, 299, 104713. doi:10.1016/j.jbc.2023.104713. https://pubmed.ncbi.nlm.nih.gov/37061003/
6. Zhang, Xiao, Sun, Fenyong, Qiao, Yongxia, Pan, Qiuhui, Wang, Jiayi. . TFCP2 Is Required for YAP-Dependent Transcription to Stimulate Liver Malignancy. In Cell reports, 21, 1227-1239. doi:10.1016/j.celrep.2017.10.017. https://pubmed.ncbi.nlm.nih.gov/29091762/
7. Li, Yuan, Li, Dan, Wang, Jingyu, Tang, Jinlong. 2023. Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis. In Diagnostic pathology, 18, 41. doi:10.1186/s13000-023-01330-y. https://pubmed.ncbi.nlm.nih.gov/36998041/
智鼠故事 
